Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/11269740

Download in:

View as

General Info

PMID
11269740